The 3D diagnostic imaging services market consists of revenues generated by the use of 3D diagnostic imaging procedures such as 3D X-rays, 3D ultrasound, MRI, and other 3D nuclear imaging techniques (PET, SPECT) to diagnose patients with chronic diseases.
The global 3D diagnostic imaging services market is expected to decline from $179.9 billion in 2019 to $172.25 billion in 2020 at a compound annual growth rate (CAGR) of -4.22%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The market is then expected to recover and reach $221.2 billion in 2023 at CAGR of 8.69%.
